Piperacillin (sodium)

CAT:
804-HY-B1286-01
Size:
100 mg

For Laboratory Research Only. Not for Clinical or Personal Use.

  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Piperacillin (sodium) - image 1

Piperacillin (sodium)

  • UNSPSC Description:

    Piperacillin sodium is a semisynthetic broad-spectrum β-lactam antibiotic which exhibits potent bactericidal activity against Gram-negative bacteria as well as select Gram-positive strains through penicillin-binding proteins. Piperacillin is most commonly used in combination with the β-lactamase inhibitor Tazobactam[1][2][3].
  • Target Antigen:

    Antibiotic; Bacterial; Penicillin-binding protein (PBP)
  • Type:

    Reference compound
  • Related Pathways:

    Anti-infection
  • Applications:

    COVID-19-immunoregulation
  • Field of Research:

    Infection; Cancer
  • Assay Protocol:

    https://www.medchemexpress.com/Piperacillin-sodium.html
  • Purity:

    98.01
  • Solubility:

    DMSO : 100 mg/mL (ultrasonic)|H2O : ≥ 100 mg/mL
  • Smiles:

    O=C([C@@H](C(C)(C)S[C@]1([H])[C@@H]2NC([C@H](NC(N3C(C(N(CC)CC3)=O)=O)=O)C4=CC=CC=C4)=O)N1C2=O)O[Na]
  • Molecular Weight:

    539.54
  • References & Citations:

    [1]Tan JS, et al. Antipseudomonal penicillins. Med Clin North Am. 1995 Jul;79(4):679-93.|[2]Lau WK, et al. Randomized, open-label, comparative study of piperacillin-tazobactam administered by continuous infusion versus intermittent infusion for treatment of hospitalized patients with complicated intra-abdominal infection. Antimicrob Agents Chemother. 2006 Nov;50(11):3556-61.|[3]Fu KP, et al. Piperacillin, a new penicillin active against many bacteria resistant to other penicillins. Antimicrob Agents Chemother. 1978 Mar;13(3):358-67.|[4]Fu KP, et al. Piperacillin, a new penicillin active against many bacteria resistant to other penicillins. Antimicrob Agents Chemother. 1978,13(3):358-67.|[5]Bodey GP, et al. Piperacillin: In Vitro Evaluation. Antimicrob Agents Chemother. 1978,14(1):78-87.|[6]Harada Y, et al. In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae. Clin Microbiol Infect. 2014,20(11):O831-9.Biomed Res Int. 2018 Jul 2;2018:3579832. |bioRxiv. 2024 May 10.|Nat Commun. 2022 Mar 2;13(1):1116.|Antimicrob Agents Chemother. 2023 May 18;e0160322.|Microbiol Spectr. 2022 Dec 8;e0303822.|Microbiol Spectr. 2023 Apr 24;e0069223.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    4°C (Powder, sealed storage, away from moisture)
  • Clinical Information:

    Launched
  • CAS Number:

    59703-84-3